Literature DB >> 31331936

Autophosphorylation activates c-Src kinase through global structural rearrangements.

Edgar E Boczek1, Qi Luo2, Marco Dehling3, Michael Röpke4, Sophie L Mader4, Andreas Seidl5, Ville R I Kaila6, Johannes Buchner7.   

Abstract

The prototypical kinase c-Src plays an important role in numerous signal transduction pathways, where its activity is tightly regulated by two phosphorylation events. Phosphorylation at a specific tyrosine by C-terminal Src kinase inactivates c-Src, whereas autophosphorylation is essential for the c-Src activation process. However, the structural consequences of the autophosphorylation process still remain elusive. Here we investigate how the structural landscape of c-Src is shaped by nucleotide binding and phosphorylation of Tyr416 using biochemical experiments, hydrogen/deuterium exchange MS, and atomistic molecular simulations. We show that the initial steps of kinase activation involve large rearrangements in domain orientation. The kinase domain is highly dynamic and has strong cross-talk with the regulatory domains, which are displaced by autophosphorylation. Although the regulatory domains become more flexible and detach from the kinase domain because of autophosphorylation, the kinase domain gains rigidity, leading to stabilization of the ATP binding site and a 4-fold increase in enzymatic activity. Our combined results provide a molecular framework of the central steps in c-Src kinase regulation process with possible implications for understanding general kinase activation mechanisms.
© 2019 Boczek et al.

Entities:  

Keywords:  ATP; Src; activation; biophysics; conformational change; enzyme mechanism; hydrogen/deuterium exchange; molecular dynamics; oncogene; phosphorylation; protein kinase

Mesh:

Substances:

Year:  2019        PMID: 31331936      PMCID: PMC6721954          DOI: 10.1074/jbc.RA119.008199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation.

Authors:  M A Young; S Gonfloni; G Superti-Furga; B Roux; J Kuriyan
Journal:  Cell       Date:  2001-04-06       Impact factor: 41.582

Review 2.  The conformational plasticity of protein kinases.

Authors:  Morgan Huse; John Kuriyan
Journal:  Cell       Date:  2002-05-03       Impact factor: 41.582

3.  Src kinase activation by direct interaction with the integrin beta cytoplasmic domain.

Authors:  Elena G Arias-Salgado; Sergio Lizano; Sugata Sarkar; Joan S Brugge; Mark H Ginsberg; Sanford J Shattil
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-30       Impact factor: 11.205

4.  Crystal structures of c-Src reveal features of its autoinhibitory mechanism.

Authors:  W Xu; A Doshi; M Lei; M J Eck; S C Harrison
Journal:  Mol Cell       Date:  1999-05       Impact factor: 17.970

5.  The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation.

Authors:  Sandra W Cowan-Jacob; Gabriele Fendrich; Paul W Manley; Wolfgang Jahnke; Doriano Fabbro; Janis Liebetanz; Thomas Meyer
Journal:  Structure       Date:  2005-06       Impact factor: 5.006

Review 6.  Src kinase regulation by phosphorylation and dephosphorylation.

Authors:  Robert Roskoski
Journal:  Biochem Biophys Res Commun       Date:  2005-05-27       Impact factor: 3.575

7.  Crystal structures of active SRC kinase domain complexes.

Authors:  Christine B Breitenlechner; Norman A Kairies; Konrad Honold; Stefan Scheiblich; Hans Koll; Eva Greiter; Stefan Koch; Wolfgang Schäfer; Robert Huber; Richard A Engh
Journal:  J Mol Biol       Date:  2005-10-21       Impact factor: 5.469

Review 8.  Src protein-tyrosine kinase structure and regulation.

Authors:  Robert Roskoski
Journal:  Biochem Biophys Res Commun       Date:  2004-11-26       Impact factor: 3.575

9.  Regulation of both apoptosis and cell survival by the v-Src oncoprotein.

Authors:  D Johnson; M Agochiya; K Samejima; W Earnshaw; M Frame; J Wyke
Journal:  Cell Death Differ       Date:  2000-08       Impact factor: 15.828

10.  Purification and biochemical characterization of non-myristoylated recombinant pp60c-src kinase.

Authors:  N B Lydon; B Gay; H Mett; B Murray; J Liebetanz; A Gutzwiller; H Piwnica-Worms; T M Roberts; E McGlynn
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

View more
  6 in total

1.  Biliverdin reductase bridges focal adhesion kinase to Src to modulate synaptic signaling.

Authors:  Chirag Vasavda; Evan R Semenza; Jason Liew; Ruchita Kothari; Ryan S Dhindsa; Shruthi Shanmukha; Anthony Lin; Robert Tokhunts; Cristina Ricco; Adele M Snowman; Lauren Albacarys; Francesco Pastore; Cristian Ripoli; Claudio Grassi; Eugenio Barone; Michael D Kornberg; Xinzhong Dong; Bindu D Paul; Solomon H Snyder
Journal:  Sci Signal       Date:  2022-05-10       Impact factor: 9.517

2.  Molecular dynamics simulations of the conformational plasticity in the active pocket of salt-inducible kinase 2 (SIK2) multi-state binding with bosutinib.

Authors:  Mingsong Shi; Lun Wang; Kongjun Liu; Yong Chen; Mengshi Hu; Linyu Yang; Jun He; Lijuan Chen; Dingguo Xu
Journal:  Comput Struct Biotechnol J       Date:  2022-05-23       Impact factor: 6.155

3.  CSK-homologous kinase (CHK/MATK) is a potential colorectal cancer tumour suppressor gene epigenetically silenced by promoter methylation.

Authors:  Anderly C Chüeh; Gahana Advani; Momeneh Foroutan; Jai Smith; Nadia Ng; Harshal Nandurkar; Daisy S Lio; Hong-Jian Zhu; Yuh-Ping Chong; Heather Verkade; Donald J Fujita; Jeffrey Bjorge; Faiza Basheer; Jet Phey Lim; Ian Luk; Amardeep Dhillon; Anuratha Sakthianandeswaren; Dmitri Mouradov; Oliver Sieber; Frédéric Hollande; John M Mariadason; Heung-Chin Cheng
Journal:  Oncogene       Date:  2021-03-25       Impact factor: 9.867

4.  Anti-Survival Effect of SI306 and Its Derivatives on Human Glioblastoma Cells.

Authors:  Lorenzo Monteleone; Barbara Marengo; Francesca Musumeci; Giancarlo Grossi; Anna Carbone; Giulia E Valenti; Cinzia Domenicotti; Silvia Schenone
Journal:  Pharmaceutics       Date:  2022-07-01       Impact factor: 6.525

Review 5.  PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential.

Authors:  Hai Huang; Mee-Hyun Lee; Kangdong Liu; Zigang Dong; Zeayoung Ryoo; Myoung Ok Kim
Journal:  Cancers (Basel)       Date:  2021-05-06       Impact factor: 6.639

Review 6.  Nuclear Functions of the Tyrosine Kinase Src.

Authors:  Giulia Bagnato; Martina Leopizzi; Enrica Urciuoli; Barbara Peruzzi
Journal:  Int J Mol Sci       Date:  2020-04-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.